Craft

DermTech

Stock Price

$0

2024-08-28

Market Capitalization

$3.3 M

2024-08-27

Revenue

$15.3 M

FY, 2023

DermTech Summary

Company Summary

Overview
DermTech is a diagnostics company developing and marketing non-invasive gene expression tests. It aims to provide aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. The company provides an alternative to surgical biopsy and analyzes skin biopsy samples collected non-invasively using an adhesive patch.
Type
Public
Status
Active
Founded
1996
HQ
San Diego, CA, US | view all locations
Website
https://dermtech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Kevin Sun

    Kevin Sun, Chief Financial Officer

  • Ray Akhavan
  • Claudia Ibarra

    Claudia Ibarra, Chief Operating Officer

  • Daniel Visage

    Daniel Visage, Senior Vice President, Payer Access

LocationsView all

1 location detected

  • San Diego, CA HQ

    United States

    11099 N Torrey Pines Rd #100, La Jolla

DermTech Financials

Summary Financials

Revenue (Q1, 2024)
$3.8M
Gross profit (Q1, 2024)
$713.0K
Net income (Q1, 2024)
($20.0M)
Cash (Q1, 2024)
$27.6M
EBIT (Q1, 2024)
($20.5M)
Enterprise value
($21.1M)

Footer menu